's Avatar

@hideta77.bsky.social

9 Followers  |  17 Following  |  3 Posts  |  Joined: 25.01.2025  |  1.6749

Latest posts by hideta77.bsky.social on Bluesky

Post image

#EACS2025 - Toshibumi Taniguch from #Japan is talking about #HIV and #Virology. Reservoir persistence remains the major obstacle. The capsid inhibitors and long-acting agents expand suppression strategies.

15.10.2025 09:15 β€” πŸ‘ 6    πŸ” 3    πŸ’¬ 1    πŸ“Œ 0
Video thumbnail

πŸ‘©β€βš•οΈπŸ‘¨β€πŸ”¬ Why do people attend #EACS2025? Hear it straight from previous participants! Watch their testimonials and see why Paris is the place to be this October. 🌟 Register now and join the global conversation on HIV: https://loom.ly/cOdLETc
#HIV #EACS2025 #Paris #MedicalCommunity

30.09.2025 07:05 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
20th European AIDS Conference I Hear from the participants!
YouTube video by European AIDS Clinical Society 20th European AIDS Conference I Hear from the participants!

www.youtube.com/watch?v=-1rP...

29.09.2025 12:55 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Evaluation of cabotegravir plus rilpivirine in routine clinical settings in Japan: A multicentre study of efficacy, safety and biomarker dynamics Objectives Long-acting cabotegravir plus rilpivirine (CAB+RPV) offers an alternative to daily oral therapy, but real-world data in East Asia remain scarce. This study aims to evaluate the impact of ...

Pleased to inform that a consortium of Japanese doctors has published a paper on LAI. I’m honored to be listed as a co-author. Prof. Orkin encouraged us to form the consortium. We appreciate your support. @profchloeorkin.bsky.social @toshtaniguc.bsky.social

onlinelibrary.wiley.com/doi/10.1111/...

13.08.2025 02:45 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Congrats!!!πŸ‘

19.03.2025 03:27 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

@hideta77 is following 17 prominent accounts